Atria Wealth Solutions Inc. Sells 270 Shares of CME Group Inc. (NASDAQ:CME)

Atria Wealth Solutions Inc. cut its position in CME Group Inc. (NASDAQ:CMEFree Report) by 5.0% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 5,182 shares of the financial services provider’s stock after selling 270 shares during the period. Atria Wealth Solutions Inc.’s holdings in CME Group were worth $1,038,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently made changes to their positions in the company. State Street Corp raised its stake in shares of CME Group by 3.6% in the second quarter. State Street Corp now owns 15,950,459 shares of the financial services provider’s stock valued at $2,955,461,000 after buying an additional 555,878 shares during the period. Capital Research Global Investors raised its stake in shares of CME Group by 11.6% in the second quarter. Capital Research Global Investors now owns 9,174,786 shares of the financial services provider’s stock valued at $1,699,995,000 after buying an additional 951,953 shares during the period. Geode Capital Management LLC raised its stake in shares of CME Group by 2.5% in the second quarter. Geode Capital Management LLC now owns 7,259,100 shares of the financial services provider’s stock valued at $1,342,679,000 after buying an additional 173,800 shares during the period. Bank of New York Mellon Corp raised its stake in shares of CME Group by 0.5% in the third quarter. Bank of New York Mellon Corp now owns 6,913,562 shares of the financial services provider’s stock valued at $1,224,597,000 after buying an additional 31,354 shares during the period. Finally, Parnassus Investments LLC raised its stake in shares of CME Group by 10.0% in the second quarter. Parnassus Investments LLC now owns 5,676,680 shares of the financial services provider’s stock valued at $1,051,832,000 after buying an additional 516,799 shares during the period. 85.69% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, insider Derek Sammann sold 1,862 shares of the business’s stock in a transaction dated Monday, December 4th. The stock was sold at an average price of $222.07, for a total transaction of $413,494.34. Following the completion of the transaction, the insider now directly owns 9,694 shares in the company, valued at $2,152,746.58. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other news, Director Bryan T. Durkin sold 5,560 shares of the company’s stock in a transaction dated Monday, December 11th. The stock was sold at an average price of $216.37, for a total value of $1,203,017.20. Following the completion of the transaction, the director now directly owns 62,452 shares in the company, valued at approximately $13,512,739.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Derek Sammann sold 1,862 shares of the company’s stock in a transaction dated Monday, December 4th. The stock was sold at an average price of $222.07, for a total value of $413,494.34. Following the completion of the transaction, the insider now owns 9,694 shares of the company’s stock, valued at $2,152,746.58. The disclosure for this sale can be found here. Insiders sold a total of 18,103 shares of company stock worth $3,971,672 over the last ninety days. 0.30% of the stock is owned by corporate insiders.

CME Group Price Performance

CME Group stock opened at $206.82 on Tuesday. CME Group Inc. has a 52 week low of $174.01 and a 52 week high of $223.80. The business has a 50-day simple moving average of $206.74 and a 200 day simple moving average of $207.97. The company has a quick ratio of 1.03, a current ratio of 1.03 and a debt-to-equity ratio of 0.12. The stock has a market cap of $74.45 billion, a price-to-earnings ratio of 24.68, a PEG ratio of 2.37 and a beta of 0.48.

CME Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 26th. Investors of record on Friday, March 8th will be given a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.22%. This is a boost from CME Group’s previous quarterly dividend of $1.10. The ex-dividend date of this dividend is Thursday, March 7th. CME Group’s payout ratio is presently 52.51%.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on CME shares. Morgan Stanley boosted their target price on CME Group from $215.00 to $220.00 and gave the company an “equal weight” rating in a research note on Thursday, October 26th. The Goldman Sachs Group lowered CME Group from a “neutral” rating to a “sell” rating and set a $195.00 price objective on the stock. in a research note on Wednesday, January 3rd. Rosenblatt Securities reiterated a “sell” rating and set a $180.00 price objective on shares of CME Group in a research note on Thursday, January 4th. Finally, Barclays lowered CME Group from an “overweight” rating to an “equal weight” rating and decreased their price objective for the company from $244.00 to $222.00 in a research note on Monday, January 8th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $213.89.

Check Out Our Latest Research Report on CME Group

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.